Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 3
2010 2
2011 2
2012 3
2013 3
2014 2
2015 3
2016 4
2017 4
2020 1
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean gadobenate sodium (6 results)?
Assessment of hepatitis and fibrosis using Gd-EOB-DTPA MRI in dogs.
Tanaka T, Nishida H, Mie K, Yamazaki H, Lin LS, Akiyoshi H. Tanaka T, et al. Vet Rec Open. 2020 Aug 3;7(1):e000371. doi: 10.1136/vetreco-2019-000371. eCollection 2020. Vet Rec Open. 2020. PMID: 32818058 Free PMC article.
BACKGROUND: Gadoxetate sodium (Gd-EOB-DTPA) is taken into hepatocytes and excreted into the bile. ...
BACKGROUND: Gadoxetate sodium (Gd-EOB-DTPA) is taken into hepatocytes and excreted into the bile. ...
Benign Hepatocellular Nodules: Hepatobiliary Phase of Gadoxetic Acid-enhanced MR Imaging Based on Molecular Background.
Yoneda N, Matsui O, Kitao A, Kozaka K, Kobayashi S, Sasaki M, Yoshida K, Inoue D, Minami T, Gabata T. Yoneda N, et al. Radiographics. 2016 Nov-Dec;36(7):2010-2027. doi: 10.1148/rg.2016160037. Epub 2016 Oct 14. Radiographics. 2016. PMID: 27740898 Review.
Gadoxetic acid is a contrast agent for magnetic resonance (MR) imaging with hepatocyte-specific properties and is becoming increasingly important in detection and characterization of hepatocellular carcinoma and benign hepatocellular nodules, including focal nodular hyperp …
Gadoxetic acid is a contrast agent for magnetic resonance (MR) imaging with hepatocyte-specific properties and is becoming increasing …
Reducing Artifacts during Arterial Phase of Gadoxetate Disodium-enhanced MR Imaging: Dilution Method versus Reduced Injection Rate.
Kim YK, Lin WC, Sung K, Raman SS, Margolis D, Lim Y, Gu S, Lu D. Kim YK, et al. Radiology. 2017 May;283(2):429-437. doi: 10.1148/radiol.2016160241. Epub 2016 Dec 15. Radiology. 2017. PMID: 27977329
A total of 318 consecutive patients undergoing gadoxetic acid-enhanced MR imaging were placed into one of two subcohorts of 159 consecutive patients each: the dilution subcohort (gadoxetic acid was diluted 1:1 with saline and injected at a rate of 2.0 mL/sec) and th …
A total of 318 consecutive patients undergoing gadoxetic acid-enhanced MR imaging were placed into one of two subcohorts of 159 conse …
Analytical Interference by Contrast Agents in Biochemical Assays.
Otnes S, Fogh-Andersen N, Rømsing J, Thomsen HS. Otnes S, et al. Contrast Media Mol Imaging. 2017 Apr 10;2017:1323802. doi: 10.1155/2017/1323802. eCollection 2017. Contrast Media Mol Imaging. 2017. PMID: 29097910 Free PMC article.
MATERIALS AND METHODS: The effects of five CAs, gadobutrol, gadoterate meglumine, gadoxetate disodium, iodixanol, and iomeprol, were studied on the 29 most frequently performed biochemical assays. ...Iomeprol produced a negative interference on the bicarbonate (p = 0.0057) …
MATERIALS AND METHODS: The effects of five CAs, gadobutrol, gadoterate meglumine, gadoxetate disodium, iodixanol, and iomeprol, were …
MRI assessment of biliary ductal obstruction: is there added value of T1-weighted gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced MR cholangiography?
Reiner CS, Merkle EM, Bashir MR, Walle NL, Nazeer HK, Gupta RT. Reiner CS, et al. AJR Am J Roentgenol. 2013 Jul;201(1):W49-56. doi: 10.2214/AJR.12.9332. AJR Am J Roentgenol. 2013. PMID: 23789696

RESULTS: Overall sensitivity across all readers in diagnosing significance of obstruction was 60% without gadoxetate disodium-enhanced MRC and 91% with gadoxetate disodium- enhanced MRC (p < 0.001). ...Confidence in final diagnosis was significantly higher with a

…
RESULTS: Overall sensitivity across all readers in diagnosing significance of obstruction was 60% without gadoxetate disodium-enhance …
Features of acute liver congestion on gadoxetate disodium-enhanced MRI in a rat model: Role of organic anion-transporting polypeptide 1A1.
Shimizu A, Kobayashi A, Motoyama H, Sakai H, Yamada A, Yoshizawa A, Momose M, Kadoya M, Miyagawa S. Shimizu A, et al. J Magn Reson Imaging. 2015 Sep;42(3):828-36. doi: 10.1002/jmri.24839. Epub 2015 Jan 8. J Magn Reson Imaging. 2015. PMID: 25581836
PURPOSE: To evaluate the features of hepatic congestion on gadoxetate disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI) and the mechanisms responsible for the radiological findings in a rat model of partial liver congestion. ...
PURPOSE: To evaluate the features of hepatic congestion on gadoxetate disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI …
Hepatic uptake of gadoxetic acid.
Kim H, Kim MJ. Kim H, et al. Radiology. 2013 Apr;267(1):314-5. doi: 10.1148/radiol.13122292. Radiology. 2013. PMID: 23525720 No abstract available.
Correlation of liver enhancement in gadoxetic acid-enhanced MRI with liver functions: a multicenter-multivendor analysis of hepatocellular carcinoma patients from SORAMIC trial.
Öcal O, Peynircioglu B, Loewe C, van Delden O, Vandecaveye V, Gebauer B, Zech CJ, Sengel C, Bargellini I, Iezzi R, Benito A, Schütte K, Gasbarrini A, Seidensticker R, Wildgruber M, Pech M, Malfertheiner P, Ricke J, Seidensticker M. Öcal O, et al. Eur Radiol. 2022 Feb;32(2):1320-1329. doi: 10.1007/s00330-021-08218-9. Epub 2021 Aug 31. Eur Radiol. 2022. PMID: 34467453 Free PMC article.
CONCLUSIONS: The liver enhancement on the hepatobiliary phase of gadoxetic acid-enhanced MRI is correlated with biomarkers of liver functions in a multicenter cohort. ...KEY POINTS: The correlation between liver enhancement on the hepatobiliary phase of gadoxetic ac …
CONCLUSIONS: The liver enhancement on the hepatobiliary phase of gadoxetic acid-enhanced MRI is correlated with biomarkers of liver f …
[Optimal scan timing for Gd-EOB-DTPA enhanced liver dynamic MR imaging].
Akimoto S, Mori H, Fujii T, Furuya K. Akimoto S, et al. Nihon Hoshasen Gijutsu Gakkai Zasshi. 2009 May 20;65(5):626-30. doi: 10.6009/jjrt.65.626. Nihon Hoshasen Gijutsu Gakkai Zasshi. 2009. PMID: 19498252 Free article. Japanese.
Gadoxetate Sodium (Gd-EOB-DTPA, EOB) is a new contrast agent for magnetic resonance (MR) imaging that allows both vascular and hepatobiliary imaging in one examination. ...
Gadoxetate Sodium (Gd-EOB-DTPA, EOB) is a new contrast agent for magnetic resonance (MR) imaging that allows both vascular and …
25 results